|
CN102443017A
|
|
Preparation method of cefozopran hydrochloride
|
|
CN101897667A
|
|
Doxorubicin hydrochloride liposome injection and preparation technology thereof
|
|
CN101744769A
|
|
Methods for preparing sterile powder of cefoselis sulfate
|
|
CN101712658A
|
|
1-butyl-2-hydroxy aralkyl piperazine derivative and application as antidepressant
|
|
CN101337955A
|
|
Method for preparing high optical purity 3-substituted chiral phthalide compounds
|
|
CN101579323A
|
|
Butylphenyl phthaleine sustained release tablet and preparation method thereof
|
|
CN101492405A
|
|
Method for preparing atorvastatin calcium
|
|
CN101322762A
|
|
Medicinal composition for treating diabetes
|
|
CN101270129A
|
|
Novel method for synthesizing bi-axungia acyl-phosphatidylethanolamine
|
|
CN101270130A
|
|
Method for preparing bi-axungia acyl-phosphatidylethanolamine
|
|
CN101190208A
|
|
Medicinal preparations containing duloxetine hydrochloride and preparation method thereof
|
|
CN101857536A
|
|
Refining method of 1-(4-hydroxylphengl)-2-bromopropane-1-ketone
|
|
CN1572298A
|
|
Arbidol containing compound preparation
|
